Page
%P
-
Article
STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
Immunostimulatory therapies based on pattern recognition receptors (PRRs) have emerged as an effective approach in the fight against cancer, with the ability to recruit tumor-specific lymphocytes in a low-immu...